Shefah Qazi

Shefah has over 14 years of experience in biomedical research, specializing in protein biochemistry and engineering. At Pheast, Shefah leads multiple programs that support the development and validation of our drug candidates. Before Pheast, she was a scientist at Gritstone Bio overseeing peptide-MHC I/II complex production for antibody and vaccine development in the onco-immunology space. Shefah received her post-doctoral training in molecular and cellular biology from Indiana University, a Ph.D. in biochemistry from Montana State University and a B.S. in chemistry from the University of California, Berkeley.